| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT06512688 Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults |
overall status: Recruiting → Unknown |
| 2026-08-09 | NCT06010966 Effect of iTBS on Children With ADHD |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06512701 Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver… |
overall status: Recruiting → Unknown |
| 2026-08-01 | NCT07153848 An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease |
date change Primary completion pushed: 2025-07-01 -> 2027-12-31 |
| 2026-08-01 | NCT07153848 An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease |
date change Completion pushed: 2025-12-31 -> 2027-12-31 |
| 2026-07-28 | NCT05413343 Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in… |
date change Primary completion pushed: 2025-10-31 -> 2026-12-31 |
| 2026-07-28 | NCT05413343 Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in… |
date change Completion pushed: 2025-10-31 -> 2026-12-31 |
| 2026-07-19 | NCT07707687 Safety and Efficacy of Eculizumab in High-risk TA-TMA |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-29 | NCT07735182 Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury | Recruiting | |
| 2026-07-22 | NCT07718503 A Study on the Combination of Tongluo Huayu Formula in Treating RVO of Phlegm-Stasis… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07395596 | Remimazolam for Bronchoscopy in High-Risk Patients | Pulmonary Infection | Recruiting |
| NCT07667517 | Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease | Albuminuria | Not Yet Recruiting |
| Phase 3 | |||
| NCT06361329 | Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed… | ETP-ALL | Recruiting |
| NCT06977893 | Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a… | HR+/HER2- Breast Cancer | Recruiting |
| NCT07442513 | Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT | Hematopoietic Stem Cell Transplantation | Recruiting |
| NCT07396480 | Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan… | Venentoclax | Recruiting |
| NCT07692841 | Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors | Healthy Hematopoietic Stem Cell Donor | Recruiting |
| NCT04547049 | A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From… | Leukemia | Active, Not Recruiting |
| NCT07554807 | A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial… | Nutritional Deficiency | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07651163 | Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate… | Acute Myeloid Leukemia (AML) | Enrolling by Invitation |
| NCT07651176 | Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk… | Acute Myeloid Leukemia | Enrolling by Invitation |
| Phase 2 | |||
| NCT04933669 | Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for… | Progression-free Survival | Recruiting |
| NCT06046313 | Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS | Acute Myeloid Leukemia | Recruiting |
| NCT06445881 | Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment | Non Small Cell Lung Cancer | Recruiting |
| NCT06554626 | Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL | Precursor B-Cell Lymphoblastic Leukemia | Recruiting |
| NCT06621199 | Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen… | Acute Myeloid Leukemia | Recruiting |
| NCT06705127 | Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced… | HR-positive,HER2-negative Breast Cancer | Recruiting |
| NCT06742463 | VHAG in Treating R/R T-ALL/LBL | Acute T Lymphpblastic Leukemia/Lymphoma | Recruiting |
| NCT06742515 | Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL | Precursor B-Cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06754267 | Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL | Precursor B-Cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06832904 | Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer… | HER2-positive Breast Cancer | Recruiting |
| NCT07025174 | Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer | Bile Duct Carcinoma | Recruiting |
| NCT07105579 | Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance… | Leukemia | Recruiting |
| NCT06611813 | Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer… | HR+/HER2- Breast Cancer | Recruiting |
| NCT06874933 | Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2… | HR+/HER2- Breast Cancer | Recruiting |